Inventor · disambiguated record
Kamon Shirakawa
Also filed as: SHIRAKAWA KAMON
24 granted patents·10 pending applications·203 citations·filing 1995–2022
95Inventor score
Top patents by PatentIndex Score
34 records- 0191US7977461B2Anti-platelet membrane glycoprotein VI monoclonal antibodyMOCHIDA PHARM CO LTD·Filed 2006·Granted Jul 12, 2011·18 cites·9 claims
- 0286US8389692B2Anti-platelet membrane glycoprotein VI monoclonal antibodyTAKAYAMA HIROSHI·Filed 2011·Granted Mar 5, 2013·8 cites·8 claims
- 0386US7608684B2Soluble CD14 antigenMOCHIDA PHARM CO LTD·Filed 2005·Granted Oct 27, 2009·12 cites·12 claims
- 0485US8124722B2Soluble CD14 antigenFURUSAKO SHOJI·Filed 2009·Granted Feb 28, 2012·9 cites·2 claims
- 0584US7901900B2Assay kit and antibody for human low molecular weight CD14MOCHIDA PHARM CO LTD·Filed 2007·Granted Mar 8, 2011·6 cites·5 claims
- 0681US5610016AMethod for measuring adenyl group-containing substances using heteropoly-acidMOCHIDA PHARM CO LTD·Filed 1995·Granted Mar 11, 1997·68 cites·13 claims
- 0779US6916628B1Method for the measurement of soluble CD14 proteins separatelyMOCHIDA PHARM CO LTD·Filed 2000·Granted Jul 12, 2005·12 cites·15 claims
- 0879US6114507AAnti-Fas ligand antibody and assay method using the anti-Fas ligand antibodyMOCHIDA PHARM CO LTD·Filed 1996·Granted Sep 5, 2000·33 cites·23 claims
- 0974US8524870B2Anti-platelet membrane glycoprotein VI monoclonal antibodyMOCHIDA PHARM CO LTD·Filed 2012·Granted Sep 3, 2013·1 cites·8 claims
- 1074US7605226B2MeltrinsMOCHIDA PHARM CO LTD·Filed 2006·Granted Oct 20, 2009·2 cites·7 claims
- 1173US11685788B2Anti-presepsin antibodyMOCHIDA PHARM CO LTD·Filed 2020·Granted Jun 27, 2023·0 cites·2 claims
- 1271US9297802B2Diagnosis of respiratory tract infectious diseases using urine specimensSHIRAKAWA KAMON·Filed 2012·Granted Mar 29, 2016·2 cites·16 claims
- 1370US7465547B2Methods for detecting human low molecular weight CD14MOCHIDA PHARM CO LTD·Filed 2003·Granted Dec 16, 2008·7 cites·8 claims
- 1468US7060791B2MeltrinsMOCHIDA PHARM CO LTD·Filed 2001·Granted Jun 13, 2006·4 cites·2 claims
- 1565US7264967B2Anti-CD14 monoclonal antibody having effect of inhibiting CD14/TLR bindingMOCHIDA PHARM CO LTD·Filed 2001·Granted Sep 4, 2007·2 cites·15 claims
- 1664US10676532B2Anti-presepsin antibodyMOCHIDA PHARM CO LTD·Filed 2018·Granted Jun 9, 2020·0 cites·16 claims
- 1762US2014044723A1Anti-platelet membrane glycoprotein vi monoclonal antibodyMOCHIDA PHARM CO LTD·Filed 2013·Application pending·0 cites
- 1859US9951142B2Anti-presepsin antibodyMOCHIDA PHARM CO LTD·Filed 2015·Granted Apr 24, 2018·0 cites·16 claims
- 1959US2009041783A1Anti-platelet membrane glycoprotein vi monoclonal antibodyMOCHIDA PHARM CO LTD·Filed 2006·Application pending·0 cites
- 2054US2024302385A1Biomarker for detecting tubulointerstitial disorder and use thereofPHC CORP·Filed 2022·Application pending·0 cites
- 2151US2024288435A1Method for predicting risk for thrombosis in cancer patient using soluble clec2PHC CORP·Filed 2022·Application pending·0 cites
- 2250US10024869B2Diagnosis of respiratory tract infectious disease using blood specimensMOCHIDA PHARM CO LTD·Filed 2016·Granted Jul 17, 2018·0 cites·20 claims
- 2350US9291631B2Diagnosis of respiratory tract infectious disease using blood specimensSHIRAKAWA KAMON·Filed 2012·Granted Mar 22, 2016·0 cites·16 claims
- 2449US11117974B2Specifically purified anti-presepsin antibodyMOCHIDA PHARM CO LTD·Filed 2015·Granted Sep 14, 2021·0 cites·20 claims
- 2547US10054585B2Diagnosis of respiratory tract infectious disease using urine specimensMOCHIDA PHARM CO LTD·Filed 2016·Granted Aug 21, 2018·0 cites·20 claims
- 2646US2005154192A1Anti-il13 receptor alpha1 neutralizing antibodyFiled 2002·Application pending·0 cites
- 2745US5744307AMethod for measuring adenyl group-containing susbstancesMOCHIDA PHARM CO LTD·Filed 1995·Granted Apr 28, 1998·13 cites·24 claims
- 2845US2007025992A1Monoclonal antibody against platelet membrane glycoprotein VIMOCHIDA PHARM CO LTD·Filed 2004·Application pending·0 cites
- 2944US2004092712A1Tlr/cd14 binding inhibitorFiled 2001·Application pending·0 cites
- 3042US6096312AAgent for suppressing a reduction of CD4+ lymphocytesMOCHIDA PHARM CO LTD·Filed 1998·Granted Aug 1, 2000·6 cites·4 claims
- 3142US2004076992A1Novel cell adhesion molecule specific to activated leukocyteFiled 2002·Application pending·0 cites
- 3241US2008292619A1Pharmaceutical Composition Containing Meltrin AntagonistMOCHIDA PHARM CO LTD·Filed 2005·Application pending·0 cites
- 3338US2013280252A1Method for selecting patient to be given drug for treating septicemiaIMAI MARIKO·Filed 2012·Application pending·0 cites
- 3435US11041864B2Method for prediction of prognosis of sepsisMATSUYA TAKESHI·Filed 2012·Granted Jun 22, 2021·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Kamon Shirakawa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →